======= TADA2B ======= == Gene Information == * **Official Symbol**: TADA2B * **Official Name**: transcriptional adaptor 2B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=93624|93624]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86TJ2|Q86TJ2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TADA2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TADA2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608790|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Coactivates PAX5-dependent transcription together with either SMARCA4 or GCN5L2. {ECO:0000269|PubMed:12972612}. |Myb DNA-binding| |SAGA-type complex| |STAGA complex| |positive regulation of histone acetylation| |positive regulation of peptidyl-lysine acetylation| |positive regulation of protein acetylation| |histone acetyltransferase activity| |regulation of histone acetylation| |regulation of peptidyl-lysine acetylation| |regulation of protein acetylation| |positive regulation of histone modification| |positive regulation of chromatin organization| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |regulation of histone modification| |chromatin remodeling| |positive regulation of chromosome organization| |protein acylation| |regulation of chromatin organization| |protein deubiquitination| |transcription coactivator activity| |protein modification by small protein removal| |peptidyl-lysine modification| |regulation of chromosome organization| |histone modification| |covalent chromatin modification| |chromatin binding| |positive regulation of organelle organization| |chromatin organization| |zinc ion binding| |peptidyl-amino acid modification| |protein modification by small protein conjugation or removal| |chromosome organization| |positive regulation of cellular component organization| |positive regulation of protein modification process| |proteolysis| |regulation of organelle organization| |DNA binding| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|-1.72| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.74| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|1.79| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.03| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|2.07| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.74| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|3.32| ^Gene^Correlation^ |[[:human genes:s:supt7l|SUPT7L]]|0.725| |[[:human genes:t:taf6l|TAF6L]]|0.667| |[[:human genes:t:taf5l|TAF5L]]|0.652| |[[:human genes:t:tada1|TADA1]]|0.604| |[[:human genes:t:tada3|TADA3]]|0.56| |[[:human genes:k:kat2a|KAT2A]]|0.556| |[[:human genes:m:med13l|MED13L]]|0.55| |[[:human genes:m:med13|MED13]]|0.543| |[[:human genes:s:supt20h|SUPT20H]]|0.517| |[[:human genes:a:atxn7|ATXN7]]|0.508| |[[:human genes:c:ccdc101|CCDC101]]|0.496| |[[:human genes:m:med7|MED7]]|0.474| |[[:human genes:p:prr12|PRR12]]|0.457| |[[:human genes:m:mllt1|MLLT1]]|0.456| |[[:human genes:b:brpf1|BRPF1]]|0.448| |[[:human genes:z:zmiz1|ZMIZ1]]|0.445| |[[:human genes:g:gltscr1|GLTSCR1]]|0.443| |[[:human genes:m:med23|MED23]]|0.44| |[[:human genes:u:usp22|USP22]]|0.438| |[[:human genes:i:id3|ID3]]|0.435| |[[:human genes:u:ube3a|UBE3A]]|0.422| |[[:human genes:t:tle4|TLE4]]|0.422| |[[:human genes:r:runx1|RUNX1]]|0.419| |[[:human genes:t:tceb3|TCEB3]]|0.413| |[[:human genes:p:prkar1a|PRKAR1A]]|0.402| |[[:human genes:a:atxn7l3|ATXN7L3]]|0.4| Global Fraction of Cell Lines Where Essential: 20/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/25| |breast|4/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|2/13| |fibroblast|0/1| |gastric|1/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|1/1| |skin|1/24| |soft tissue|0/7| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 581 * **Expression level (log2 read counts)**: 5.18 {{:chemogenomics:nalm6 dist.png?nolink |}}